Solid Biosciences (SLDB) Tops Q4 EPS by 17c
Solid Biosciences (NASDAQ: SLDB) reported Q4 EPS of ($0.53), $0.17 better than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.
Solid Biosciences (NASDAQ: SLDB) reported Q4 EPS of ($0.53), $0.17 better than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.